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Abstract
Background: The ‘Worse-Stable-Better’ (W-S-B) question was introduced to capture patient-perceived change in
University of Washington Quality of Life (UW-QOL) domains.
Methods: 202 head and neck cancer patients in remission prospectively completed UW-QOL and Patients
Concerns Inventory (PCI). For each UW-QOL domain, patients indicated whether over the last month things had
worsened (W), remained stable (S) or were better (B).
Results: 202 patients at 448 attendances selected 1752 PCI items they wanted to discuss in consultation, and 58%
(1024/1752) of these were not covered by the UW-QOL. UW-QOL algorithms highlighted another 440 significant
problems that the patient did not want to discuss (i.e. the corresponding items on the PCI were not selected).
After making allowance for UW-QOL algorithms to identify 'significant problems' and PCI selection of corresponding
issues for discussion there remained clear residual and notable variation in W-S-B responses, in particular to identify
patients with significant problems that were getting worse, and patients without significant problems that wanted
to discuss issues that were getting worse. Changes in mean UW-QOL scores were notably lower for those getting
worse on the W-S-B question, typically by 10 or more units a magnitude that suggests clinically important changes
in score.
Conclusions: The W-S-B question adds little questionnaire burden and could help to better identify patients who
might benefit from intervention. The results of this study suggest that the UW-QOL with the W-S-B modification
should be used together with the PCI to allow optimal identification of issues for patient-clinician discussion during
routine outpatient clinics.
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Introduction
Communication between patient and clinician is critical
to patient-centred care in oncology [1]. Nevertheless,
there are many barriers to effective communication.
Within a head and neck cancer (HNC) setting some
patients are unwilling to disclose worries and to discuss
sensitive issues [2]. Patients with lower self-esteem can
find clinical settings intimidating and are unable to voice
their concerns, despite regular attendance to these
clinics [3]. Furthermore, clinic settings can be hectic and
demanding. Patients may be anxious or unwell and may
have to wait a long time before being seen. Clinicians
are under pressure to perform cancer surveillance tasks,
examine prosthesis/wounds and provide information,
advice and reassurances during this small window of op-
portunity. Thus, some patient issues or concerns may be
missed completely [4] or only superficially addressed [5],
resulting in unmet needs.
Post-treatment HNC survivors suffer morbidity from
functional deficits and facial disfigurement, live with
considerable symptom burden and experience substan-
tial psychosocial issues [6-11]. For some, worries about
cancer recurrence and uncertainties regarding their
future may significantly interfere with adjusting to life
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model for developing tools in shared decision-making
during survivorship because the patient-centred sup-
portive care required is often resource intensive and
multidisciplinary [14].
Health-related quality of life (HRQOL) is usually seen
as a secondary outcome measure for patients receiving
HNC treatment at the group level to compliment cure
and survival rates [15]. More recently, HRQOL measures
have been incorporated into routine clinical oncology
practice to monitor individual patients [16], and used to
screen individuals for significant problems thereby trig-
gering healthcare intervention [17]. Routine use of
HRQOL in oncology follow-up clinic consultations has
also aided patient-clinician communication [18-20]. By
using HRQOL more concerns can be discussed during
patient-clinician consultations [19,20], suggesting that
HRQOL tools can facilitate the expression of felt needs
by directing discussions toward these expressed needs,
thereby improving the efficiency of and satisfaction with
the consultation.
Not all HRQOL assessment tools consider the relative
importance of domains to the patient and patient per-
ceptions of importance may not be reflected in how time
is spent discussing specific concerns during a consult-
ation. Also, HRQOL questionnaires are restricted by
their wording and often just focus on dysfunction over a
relatively short period of time. The rigidity of some
HRQOL assessment tools may not accommodate the
coping and adaptation that occurs with time. Parallel
cognitive and emotional processing during coping and
adaptation [21] can result in incongruence between the
degree of dysfunction and the significance patients place
upon it [22]. For example, patients with significant dys-
function may continue to have poor HRQOL scores
even though they have positively adapted to their condi-
tion and consequently may not feel any need to discuss
it further. Alternatively, patients with very mild dysfunc-
tion may have reasonably good HRQOL scores but yet
feel a strong need for supportive care in relation to this.
Thus, HRQOL tools alone may miss the absence or
presence of a felt need to discuss the issue during
consultation.
The Liverpool Patients Concern Inventory (PCI) pro-
vides a simple, practical tool by which patients can high-
light their concerns and needs for discussion in their
consultations [23]. The concept of PCI was developed
from recognising that the routine application of HRQOL
questionnaires was inadequate as a means of identifying
individual patient concerns, needs and priorities in out-
patient settings. At Aintree hospital, the PCI has been
used alongside the University of Washington Quality of
life version 4 (UW-QOL) [24], as a means not only of
enabling patients to influence the content of theirimminent discussion but also to provide the clinician
with a fuller profile of information to help guide the
consultation. For a particular patient this information
yield could include significant UW-QOL problems the
patient wants to discuss, significant UW-QOL problems
the patient doesn't want to discuss, less significant issues
on the UW-QOL the patient wants to discuss, and other
concerns beyond the scope of the UW-QOL that the pa-
tient wants to discuss.
The PCI and UW-QOL help to focus consultations to
make them cover key issues for patients without undue
delay to the consultation. The aim of this study was to
introduce into this mix of information a ‘Worse-Stable-
Better’ (W-S-B) aspect to the UW-QOL version 4 and to
see if this additional information contributed uniquely
and usefully to the overall information yield available to
the clinician at the outset of consultation.
Methods
The study population comprised HNC patients of one
consultant (SNR) attending outpatient clinics from 1st
August 2007 to 8th July 2009. Patients on the Liverpool
oncology database were included if disease-free and
under routine follow-up at least 6 weeks after complet-
ing treatment. Patients were excluded if they were before
treatment, palliative, attending for other post-operative
wound management or were part of another outcomes
study in clinic.
Subjects were recruited prospectively while waiting to
be seen in the clinic waiting area. A touch-screen com-
puter package comprised the UW-QOL [25] and the Pa-
tient Concerns Inventory (PCI)) [23], with the program
written in Microsoft ACCESS. Patients entered their
own data via the touch screen and their data then went
directly onto the hospital drive and using normal pass-
word protection arrangements was retrievable by the
consultant in another room in clinic immediately before
seeing the patient. Only three patients that were ap-
proached refused to take part.
The Liverpool Patients Concerns Inventory (PCI) is a
holistic, patient-reported tool consisting of 54 issues (45
items from August 2007; 9 more from April 2008) and a
list of 15 professionals (healthcare and non-healthcare).
The PCI covers a range of issues including hearing, in-
timacy, fatigue, financial/benefits, PEG tube, relation-
ships, regret, support for family, wound healing, and
spiritual/religious aspects. It is completed before the
clinic consultation, enabling patients and their carers to
highlight concerns they would like to discuss during the
clinic visit, and to indicate which professionals they
would like to meet or be referred to. The content of the
PCI was formulated through the synthesis of items from
general and HNC-specific HRQOL questionnaires and
discussions with local and national focus groups of HNC
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patients, namely, the laryngectomy support group, HN
support group, patient research forum, hospital volun-
teers, ward and outpatient staff and the multidisciplinary
HNC team. Content validity was evaluated by the Liver-
pool HNC support group and as a result of this exercise,
the extra 9 items were added in April 2008.
The UW-QOL questionnaire [24] consists of 12 single
question domains, these having between 3 and 6 re-
sponse options that are scaled evenly from 0 (worst) to
100 (best) according to the hierarchy of response. An-
other question asks patients to choose up to three of
these domains that have been the most important to
them in the previous week. Patients were also asked to
state for each UW-QOL domain whether things had got
worse (W), stayed the same (S) or got better (B) over the
last month. August 2007 was the first time this W-S-B
question had been asked of patients and the exact word-
ing was ‘For each domain, please indicate if things had
got better, stayed the same or had got worse in the last
month’.
The analyses for this paper were three-fold. First,
W-S-B responses for each domain in relation to clinical
and patient characteristics were tested using the Chi-
squared test. Second, W-S-B responses were stratified
by whether patients had significant problems on the
UW-QOL and by whether corresponding PCI items
were selected, and association between ordinal W-S-B
responses and the 4 subgroups was tested using the
Kruskal-Wallis test. We defined a ‘significant problem’
on each UW-QOL domain using information from do-
main scores and domain importance and by adopting
algorithms (see footnote to Table 1) derived in earlier
work [17]. Third, UW-QOL domain scores of pairs of
clinic visits up to 6 months apart were stratified by
W-S-B response at the later clinic - these data were not
independent as some patients had more pairs of clinics
than others and hence no statistical tests were performed.
Clinical-demographic data came from the Liverpool
Head and Neck Cancer database. Many statistical tests
were performed during the analyses and because of this
we have regarded statistical significance as P< 0.01. As
the UW-QOL questionnaire is integrated into routine
clinical practice in this setting, this study was approved
by the University Hospital Aintree Clinical Audit de-
partment in the context of service evaluation.
Results
From 1 August 2007 to 8 July 2009, a total of 202
patients completed the touch-screen package of PCI and
UW-QOL at 448 clinic appointments. The mean (SD)
age of patients using the touch-screen at the first study
clinic was 63 (11) years and these clinics were a median
(IQR) of 17 (4–47) months after diagnosis of HN cancer.Of 202 patients 58% (117) were male, 78% (158) had a
SCC diagnosis, 72% (138/193) had oral cavity tumours,
78% (143/184) had clinical T1-T2 tumours, 19% (35/186)
clinical N positive tumours, 44% (89) had received HN
radiotherapy since diagnosis and 48% (96) had had free-
flap surgery.
Overall results for patients reporting their condition as
worse (W), the same (S) or better (B) over the previous
month are shown in Table 1. The only notable differ-
ences were observed in relation to time from diagnosis
(also Table 1) and there were no significant differences
(p< 0.01 chi-squared test) with gender, age at clinic
diagnosis (<55, 55–64, 65+) and whether patients ever
had radiotherapy or free-flap surgery. The only other
significant difference (P = 0.006) was for the saliva do-
main with tumour site: oral (W 12%, S 80%, B 8%), oro-
pharyngeal (W 23%, S 74%, B 3%), others (W 15%, S
55%, B 30%). For clinics held within 12 months (median
4 months), the trend for all UW-QOL domains apart
from saliva and mood (Table 1) was for more improve-
ment than deterioration. In the longer-term (median
50 months) there was an increase in patients reporting
stability in their condition for all domains apart from
saliva.
For most UW-QOL domains the distribution of patient
W-S-B responses differed (p< 0.01) between 4 groups
defined by whether patients had significant problems
and/or wanted to discuss the issue in the consultation
(Table 2). After making allowance for these associations
there remained clear residual and notable variation in
W-S-B responses. Of patients with a significant pain
problem 61% (25/41) said their pain was worse, and
hence 39% either stable (29%) or getting better (10%).
Similarly for a significant problem with mood, 59%
(20/34) said that mood was getting worse and hence
41% either stable (32%) or getting better (9%). For all
other domains less than half of patients with a signifi-
cant problem reported that things were worse (median
33%, range 20-44%, n = 10 domains), thus indicating a
minority subgroup for whom a significant problem was
worsening. Of those patients without a significant prob-
lem but wanting to discuss the issue, there was a minor-
ity subset (median 25%, range 8–45%, n = 12 domains)
whose condition was getting worse. Finally, and within
the vast majority of patients without a significant prob-
lem on a particular domain and also not wanting to dis-
cuss the issue there was a small subgroup (median 4%,
range 0.6–7%, n = 12 domains) of patients whose condi-
tion had got worse; for some domains this subgroup
claimed around half of all patients whose condition had
got worse – activity 10/17, recreation 10/18, speech 6/14.
In all, these 202 patients at 448 attendances selected
1752 items on the PCI that they would like to discuss in
consultation, and 58% (1024/1752) of these were issues
Table 1 UW-QOL W-S-B results, in relation to UW-QOL defined significant problems and corresponding items selected
on the PCI for discussion at the consultation
With ‘significant’ UW-QOL problem* With No ‘significant’ UW-QOL problem* Kruskal-Wallis
test P valueCorresponding items raised on
PCI for discussion in consultation
Corresponding items raised on
PCI for discussion in consultation
Yes No Yes No
Pain Worse 18 7 5 5
Stable 9 3 22 90 <0.001
Better 2 2 6 33
Appearance Worse 3 1 1 1
Stable 9 3 3 135 0.08
Better 2 2 5 37
Activity Worse 2 4 1 10
Stable 2 9 8 130 0.009
Better - 1 4 31
Recreation Worse 1 5 2 10
Stable 1 8 4 128 <0.001
Better - - - 43
Swallowing Worse 5 6 6 1
Stable 9 16 11 111 <0.001
Better 1 1 1 34
Chewing Worse 5 5 12 9
Stable 3 12 23 98 0.009
Better 2 - 10 23
Speech Worse 2 2 4 6
Stable 3 4 15 126 0.06
Better - 1 6 33
Shoulder Worse 4 - 8 4
Stable 6 7 12 140 <0.001
Better - - 3 18
Taste Worse 5 2 4 2
Stable 5 11 10 136 <0.001
Better - 2 3 22
Saliva Worse 3 11 10 5
Stable 8 8 11 126 <0.001
Better 1 1 1 17
Mood Worse 12 8 3 3
Stable 4 7 9 126 <0.001
Better 1 2 3 24
Anxiety Worse 12 6 3 6
Stable 3 19 12 111 <0.001
Better - 1 2 27
* Significant problem trigger criteria.
Pain, appearance, activity, recreation, mood: (scores of 0 or 25 or 50 & important).
Swallowing, speech, anxiety: (scores of 0 or 30).
Shoulder, taste, saliva: (scores or 0 or 30 & important).
Chewing: (score of 0).
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Table 2 Time from diagnosis, and whether for each UW-QOL domain patients had said that things had got worse,
stayed the same or got better over the previous month
Months from diagnosis to clinic5 P Value4
All patients (202) <12 months1 12-23 months2 24+ months3
% N % N % N % N
Pain Worse 17 (35) 21 (18) 17 (4) 13 (11)
Stable 61 (124) 56 (47) 57 (13) 72 (61) 0.26
Better 21 (43) 23 (19) 26 (6) 15 (13)
Appearance Worse 3 (6) 4 (3) 4 (1) 1 (1)
Stable 74 (150) 67 (56) 74 (17) 85 (72) 0.10
Better 23 (46) 30 (25) 22 (5) 14 (12)
Activity Worse 8 (17) 12 (10) 13 (3) 4 (3)
Stable 74 (149) 66 (55) 74 (17) 85 (72) 0.05
Better 18 (36) 23 (19) 13 (3) 12 (10)
Recreation Worse 9 (18) 10 (8) 13 (3) 7 (6)
Stable 70 (141) 62 (52) 61 (14) 82 (70) 0.03
Better 21 (43) 29 (24) 26 (6) 11 (9)
Swallowing Worse 9 (18) 8 (7) 4 (1) 11 (9)
Stable 73 (147) 71 (60) 70 (16) 79 (67) 0.29
Better 18 (37) 20 (17) 26 (6) 11 (9)
Chewing Worse 15 (31) 18 (15) 17 (4) 13 (11)
Stable 67 (136) 58 (49) 70 (16) 79 (67) 0.04
Better 17 (35) 24 (20) 13 (3) 8 (7)
Speech Worse 7 (14) 8 (7) 9 (2) 6 (5)
Stable 73 (148) 61 (51) 83 (19) 84 (71) 0.006
Better 20 (40) 31 (26) 9 (2) 11 (9)
Shoulder Worse 8 (16) 11 (10) 4 (1) 6 (5)
Stable 82 (165) 74 (62) 83 (19) 89 (76) 0.10
Better 10 (21) 14 (12) 13 (3) 5 (4)
Taste Worse 6 (13) 5 (4) 9 (2) 7 (6)
Stable 80 (162) 80 (67) 78 (18) 85 (72) 0.62
Better 13 (27) 15 (13) 13 (3) 8 (7)
Saliva Worse 14 (29) 11 (9) 13 (3) 19 (16)
Stable 76 (153) 80 (67) 74 (17) 73 (62) 0.61
Better 10 (20) 10 (8) 13 (3) 8 (7)
Mood Worse 13 (26) 17 (14) 26 (6) 4 (3)
Stable 72 (146) 68 (57) 52 (12) 86 (73) 0.003
Better 15 (30) 16 (13) 22 (5) 11 (9)
Anxiety Worse 13 (27) 13 (11) 22 (5) 9 (8)
Stable 72 (145) 70 (59) 70 (16) 78 (66) 0.47
Better 15 (30) 17 (14) 9 (2) 13 (11)
1: median 4 months, IQR 2-7 months.
2: median 17 months, IQR 15-22 months.
3: median 50 months, IQR 38-82 months.
4: chi-squared test.
5: not known for n = 10.
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Table 3 UW-QOL domain scores between 188 pairs of clinic visits (from 75 patients) up to 6 months apart, by whether




score at clinic 1
UW-QOL mean
score at clinic 2
Change in UW-QOL domain score from









Pain Worse 25 56 44 11 12 2 -12
Stable 116 71 75 16 76 24 +4
Better 47 84 90 4 28 15 +6
Appearance Worse 8 59 50 2 6 - -9
Stable 136 73 76 18 88 30 +3
Better 44 77 82 2 32 10 +5
Activity Worse 15 52 48 3 10 2 -3
Stable 128 69 66 21 92 15 -2
Better 45 75 80 5 27 13 +5
Recreation Worse 14 61 52 5 8 1 -9
Stable 138 71 72 23 87 28 +1
Better 36 87 87 9 18 9 0
Swallowing Worse 13 57 31 8 4 1 -26
Stable 141 69 71 12 111 18 +2
Better 34 80 84 3 25 6 +4
Chewing Worse 22 39 23 7 14 1 -16
Stable 137 53 55 9 110 18 +3
Better 29 76 79 2 23 4 +3
Speech Worse 11 68 59 3 8 - -9
Stable 135 79 79 11 112 12 0
Better 42 75 81 2 31 9 +6
Shoulder Worse 13 41 34 7 2 4 -7
Stable 135 78 79 18 96 21 +1
Better 40 81 85 3 30 7 +4
Taste Worse 9 43 24 4 4 1 -19
Stable 150 70 70 20 108 22 0
Better 29 76 81 1 25 3 +5
Saliva Worse 21 52 36 8 13 - -16
Stable 147 64 63 21 107 19 -1
Better 20 84 82 3 16 1 -2
Mood Worse 16 56 27 9 6 1 -30
Stable 135 73 73 36 66 33 0
Better 37 82 88 3 25 9 +6
Anxiety Worse 16 59 36 9 5 2 -23
Stable 137 68 72 17 86 34 +4
Better 35 80 88 4 19 12 +8
* Differences between mean scores of clinic 1 and clinic 2 were done at 2 decimal places and then rounded to the nearest unit.
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QOL selections alone through its algorithms and wor-
sening domains could only be matched up with 23%
(397/1752) of all PCI items selected by these patients. Inaddition, UW-QOL algorithms highlighted another 440
significant problems that the patient did not want to dis-
cuss (i.e. the corresponding items on the PCI were not
selected).
Ghazali et al. Head & Neck Oncology 2012, 4:32 Page 7 of 9
http://www.headandneckoncology.org/content/4/1/32Repeat clinic data were available for 110 patients and
75 of these had repeat clinics that were at most six
months apart (median 2.8, IQR 1.8–4.1 months apart,
n = 188 pairs of clinics). At the later clinic (clinic 2 in
Table 3) most patients (median 73%, range 62–80% over
the 12 domains) said their condition had been stable (S)
over the previous month, and for these patients their
statement was reflected in minimal changes in mean
UW-QOL scores between earlier and later clinic pairs
(median +1, range −2 to +4, n = 12 domains). Changes in
mean UW-QOL scores were higher (median +5, range
−2 to +8, n = 12 domains) for patients getting better (B),
but were notably lower (median −14, range −30 to −3,
n = 12 domains) for those getting worse (W). Also for
each domain those getting worse (W) started off at the
earlier clinic with scores lower on average than those
stable (S) or getting better (B); the tendency was thus for
those with the lowest scores at a clinic to get even lower
by the next clinic.
Discussion
This study introduced the question: ‘For each domain,
please indicate if things had got better, stayed the same
or had got worse in the last month’ into the UW-QOL
questionnaire and was used in routine clinical practice
at individual patient level. This modification to the UW-
QOL had the potential to improve its ability to target
key aspects for discussion during the clinic visit. The
study results provide evidence in support of this but they
also confirm the limitation of relying exclusively on
HRQOL tools to identify areas for clinic discussion.
The addition of the W-S-B for each domain may be
considered as a natural progression of enhancing the
clinical value of using UW-QOL in routine practice. Al-
ternative measures such as the Patient Generated Index
(PGI) [26] and the Schedule for the Evaluation of Indivi-
dualized Quality of Life - Direct Weighting (SEIQoL-
DW) [27], are time consuming for routine practice as
they involve a 3-stage process; starting with patients
nominating domains considered important, then rating
their perception of progress in each and then indicating
the relative importance of each domain. The overall
score obtained is reported as being more representative
of the individual’s health status in monitoring response
to treatment [28] and in facilitating the discussion of
QOL issues [29].
While it is important to obtain an individualized
HRQOL measure for monitoring individual response to
treatment and aiding patient-clinician communication in
routine oncology setting, it is also vital that this measure
retains its relevance at group level [30]. When this entire
cohort of survivors was evaluated for W-S-B scores, the
only consistent differences were in regard to the time
since their treatment. Patients within the first yearreported more improvement than deterioration in all
domains apart from saliva; and as time went on patients
demonstrated increasing stability in all domains except
saliva. These findings match the experience of HNC
patients and their UW-QOL scores in the first 12 months
post-treatment [31] and also those of long-term HNC
survivors [32]. The results for saliva probably reflect the
impact of radiation-induced xerostomia in those receiv-
ing radiotherapy [33] and are consistent with the
reported deterioration in salivary flow and saliva-
associated QOL measures in the first 12 months follow-
ing treatment, variable recovery in the 12–24 months
period and progressive deterioration in the long-term
[34,35].
The algorithm trigger criteria used (in Table 2) to
identify 'significant' problems on the UW-QOL could
have given rise to false negative and false-positive classi-
fication. In targeting those without significant problems
who are getting worse and those with significant pro-
blems who are getting better it may be that the W-S-B
serves as a safety net to help pick up false-negatives and
well as helping identify less-affected positives.
From Table 2 it can also be observed that in the ab-
sence of a significant problem on the UW-QOL, the
patient’s perception of things getting worse is more likely
to result in that particular domain being selected on the
PCI for discussion. The Self-Regulation model of chronic
illness [21] might explain this through changes in illness
representation, coping strategies, and appraisal of the
success of the coping efforts utilising cognitive and emo-
tional regulatory pathways. For example, a patient ex-
periencing pain (i.e. internal cue) who despite best
efforts (i.e. coping strategies) has worsened (i.e. ap-
praisal) despite minimal interruption to activities of daily
living (i.e. appraisal via cognitive pathway), has experi-
enced anxiety and distress (i.e. appraisal via emotional
pathway) and who highlights’pain’ for discussion if it is
perceived as a sign that the cancer has returned and is
incurable (i.e. illness representation). Clearly, based on
this model, HNC patients are more likely to highlight an
issue that is perceived to be of personal significance ra-
ther than simply the severity of the problem [13,36,37].
Pairs of clinics were included for the change analyses
if they were at most six months apart and then for each
pair the difference in UW-QOL domain scores were
computed. These were compared to W-S-B responses as
to whether things had got worse, stayed the same or got
better in the last month. Ringash et al. [38] defined a
minimal important difference (MID) as the smallest dif-
ference that reflects a clinically important change in
score and noted that most published estimates of MID
fall into the range 5–10% of the instrument range. In
our study, changes in mean UW-QOL scores for those
getting worse (W) were typically lower by 10 or more
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group level clinically important changes between clinics.
The narrow range of changes in score associated with
patients reporting stability fall below Ringash's 5–10%
threshold for defining a minimally important clinical dif-
ference. The W-S-B has the advantage of providing this
information from a single visit rather than from two
without the need for additional computations. This ana-
lysis was limited by repeat review clinics being almost al-
ways more than one month apart, with data that were
not independent because some patients contributed
more pairs of clinics than others. It was also conceivable
that a patient could indicate a change had occurred on
the W-S-B and for that change not to show in the UW-
QOL domain scores, this reflecting a lack of precision in
the UW-QOL single question domains and their small
number of levels of discrimination.
We found that only 42% of items highlighted on the
PCI overlapped with UW-QOL domains and only 23%
were through UW-QOL algorithms or worsening
domains. Thus there is clear value to using the PCI in
addition to the UW-QOL in identifying a wider range of
key concerns for discussion. These issues include fear of
recurrence in particular, and others like sleeping, energy
levels, lifestyle issues, support for family and financial
concerns [23].
If both UW-QOL and PCI are used together then the
W-S-B question can identify significant problems that
have got worse, and non-significant problems that
patients want to discuss and that have got worse. For
professionals not intending to use the PCI and only the
UW-QOL then the W-S-B targets significant problems
that have got worse and non-significant problems that
have got worse. Depending on actual domain scores it
might be that appropriate intervention may prevent a
worsening situation becoming a significant problem.
The study is limited in that the study population was
from a single consultant whose practice may not be typ-
ical of others. Also we only analysed items as identified
by the touch-screen before consultation and did not
consider items actually discussed between the patient
and clinician. We also did not seek patient feedback
about the W-S-B question.
In conclusion, this study found that the W-S-B ques-
tion adds little questionnaire burden and could help to
better identify patients who might benefit from interven-
tion. The UW-QOL questionnaire through its use of
UW-QOL algorithms and worsening domains through
W-S-B could only identify about one-quarter of all items
selected by patients on the PCI for discussion, which
suggests that the UW-QOL and PCI should be used to-
gether to allow optimal identification of issues for
patient-clinician discussion during routine outpatient
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